Voxel-based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter
H Vrenken, SARB Rombouts… - American journal of …, 2006 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Disease activity in normal-appearing white matter
(NAWM) in multiple sclerosis (MS) has been demonstrated in vivo with T1 relaxation time …
(NAWM) in multiple sclerosis (MS) has been demonstrated in vivo with T1 relaxation time …
White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis
Previous studies have established the clinical relevance of hypointense lesions (“black
holes”) on T1-weighted MRI as a surrogate marker for pathological change [36]. In contrast …
holes”) on T1-weighted MRI as a surrogate marker for pathological change [36]. In contrast …
Normal-appearing grey and white matter T1 abnormality in early relapsing–remitting multiple sclerosis: a longitudinal study
GR Davies, A Hadjiprocopis… - Multiple Sclerosis …, 2007 - journals.sagepub.com
Objective To investigate the presence and evolution of T1 relaxation time abnormalities in
normal-appearing white matter (NAWM) and grey matter (GM), early in the course of …
normal-appearing white matter (NAWM) and grey matter (GM), early in the course of …
T1 relaxation maps allow differentiation between pathologic tissue subsets in relapsing-remitting and secondary progressive multiple sclerosis
A Castriota-Scanderbeg, F Fasano… - Multiple Sclerosis …, 2004 - journals.sagepub.com
In an attempt to clarify whether T1 relaxation time mapping may assist in characterizing the
pathological brain tissue substrate of multiple sclerosis (MS), we compared the T1 relaxation …
pathological brain tissue substrate of multiple sclerosis (MS), we compared the T1 relaxation …
Whole-Brain T1 Mapping in Multiple Sclerosis: Global Changes of Normal-appearing Gray and White Matter1
H Vrenken, JJG Geurts, DL Knol, LN Van Dijk… - Radiology, 2006 - pubs.rsna.org
Purpose: To prospectively investigate whether T1 changes in normal-appearing white matter
(WM) and normal-appearing gray matter (GM) in multiple sclerosis (MS) are global or …
(WM) and normal-appearing gray matter (GM) in multiple sclerosis (MS) are global or …
Normal-appearing white matter changes vary with distance to lesions in multiple sclerosis
H Vrenken, JJG Geurts, DL Knol… - American journal …, 2006 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: Multiple sclerosis (MS) disease processes in normal-
appearing white matter (NAWM) may be different close to MR-visible lesions than farther …
appearing white matter (NAWM) may be different close to MR-visible lesions than farther …
Statistical estimation of T1 relaxation times using conventional magnetic resonance imaging
Quantitative T 1 maps estimate T 1 relaxation times and can be used to assess diffuse tissue
abnormalities within normal-appearing tissue. T 1 maps are popular for studying the …
abnormalities within normal-appearing tissue. T 1 maps are popular for studying the …
3 T MRI relaxometry detects T2 prolongation in the cerebral normal-appearing white matter in multiple sclerosis
MRI at 3 T has increased sensitivity in detecting overt multiple sclerosis (MS) brain lesions; a
growing body of data suggests clinically relevant damage occurs in the normal-appearing …
growing body of data suggests clinically relevant damage occurs in the normal-appearing …
[HTML][HTML] Periventricular gradient of T1 tissue alterations in multiple sclerosis
M Vaneckova, GF Piredda, M Andelova, J Krasensky… - NeuroImage: Clinical, 2022 - Elsevier
Objective Pathology in multiple sclerosis is not homogenously distributed. Recently, it has
been shown that structures adjacent to CSF are more severely affected. A gradient of brain …
been shown that structures adjacent to CSF are more severely affected. A gradient of brain …
The relationship between normal cerebral perfusion patterns and white matter lesion distribution in 1,249 patients with multiple sclerosis
CM Holland, A Charil, I Csapo, Z Liptak… - Journal of …, 2012 - Wiley Online Library
ABSTRACT BACKGROUND AND PURPOSE The pathological differences underlying the
clinical disease phases in multiple sclerosis (MS) are poorly characterized. We sought to …
clinical disease phases in multiple sclerosis (MS) are poorly characterized. We sought to …